BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shao X, Liu Z, Liu S, Lin N, Deng Y. Astragaloside IV alleviates atherosclerosis through targeting circ_0000231/miR-135a-5p/CLIC4 axis in AS cell model in vitro. Mol Cell Biochem 2021;476:1783-95. [PMID: 33439448 DOI: 10.1007/s11010-020-04035-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Wang S, Guo S, Zhang X, Yang C, Su G, Wan J. Circ_0004104 participates in the regulation of ox-LDL-induced endothelial cells injury via miR-942-5p/ROCK2 axis. BMC Cardiovasc Disord 2022;22:517. [DOI: 10.1186/s12872-022-02959-1] [Reference Citation Analysis]
2 Luo H, Chen J, Su C, Zha L. Advances in the Bioactivities of Phytochemical Saponins in the Prevention and Treatment of Atherosclerosis. Nutrients 2022;14:4998. [DOI: 10.3390/nu14234998] [Reference Citation Analysis]
3 Chen D, Du Y, Ye S, Yu J. Astragaloside IV protects against oxidized low‐density lipoprotein‐induced injury in human umbilical vein endothelial cells via the histone deacetylase 9 ( HDAC9) / NF‐κB axis. Environmental Toxicology 2022. [DOI: 10.1002/tox.23696] [Reference Citation Analysis]
4 Cheng C, Wang Y, Xue Q, Huang Y, Wang X, Liao F, Miao C. CircRnas in atherosclerosis, with special emphasis on the spongy effect of circRnas on miRnas. Cell Cycle 2022;:1-15. [PMID: 36229933 DOI: 10.1080/15384101.2022.2133365] [Reference Citation Analysis]
5 Zhi W, Liu Y, Wang X, Zhang H. Recent advances of traditional Chinese medicine for the prevention and treatment of atherosclerosis. J Ethnopharmacol 2022;:115749. [PMID: 36181983 DOI: 10.1016/j.jep.2022.115749] [Reference Citation Analysis]
6 Zou G, Zeng Y, Wang Y, Luo Y, Jan N. miR-135a-5p Suppresses TBK1 and Activates NRF2/TXNIP Antioxidant Pathway in LPS-Driven ALI in Mice. Computational and Mathematical Methods in Medicine 2022;2022:1-11. [DOI: 10.1155/2022/9088727] [Reference Citation Analysis]
7 Li M, Han B, Zhao H, Xu C, Xu D, Sieniawska E, Lin X, Kai G. Biological active ingredients of Astragali Radix and its mechanisms in treating cardiovascular and cerebrovascular diseases. Phytomedicine 2022;98:153918. [DOI: 10.1016/j.phymed.2021.153918] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Hu F, Chen X, Gao J, Shen Y, Yang J. CircDIP2C ameliorates oxidized low-density lipoprotein-induced cell dysfunction by binding to miR-556-5p to induce TET2 in human umbilical vein endothelial cells. Vascul Pharmacol 2021;139:106887. [PMID: 34147657 DOI: 10.1016/j.vph.2021.106887] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]